Advertise with us
Clinical Group

International Journal of Clinical Endocrinology and Metabolism

Recent articles to be released shortly in Volume-4

Hyperparathyroidism and Asthenia. A New Deal?

Published On: December 07, 2017 | Pages: 046 - 047

Author(s): S Li Sun Fui* and P Bonnichon
The profi le of primary hyperparathyroidism (PHPT) changed profoundly over the course of the twentieth century. The highly symptomatic forms reported in the 1960s have progressively been replaced by forms with few symptoms and in some cases totally asymptomatic forms. ...
Abstract View Full Article View DOI: 10.17352/ijcem.000028

Diabetic Retinopathy: Focus on Minority Populations

Published On: November 11, 2017 | Pages: 034 - 045

Author(s): Arpine Barsegian, Boleslav Kotlyar, Justin Lee, Moro O Salifu and Samy I McFarlane*
Diabetic retinopathy is a major cause of blindness in the United States. With rise of the epidemic of obesity and diabetes in the USA and around the globe, serious and common diabetic complications are evolving as a major public health problem, particularly among minority populations. ...
Abstract View Full Article View DOI: 10.17352/ijcem.000027

Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome

Published On: November 01, 2017 | Pages: 029 - 033

Author(s): Rim Hanna*, Tarek Wehbe and Elizabeth Abou Jaoude
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. The pathogenesis has not been fully deciphered. PCOS is associated with insulin resistance (IR), menstrual irregularities, cardiovascular disease, obesity, hirsutism, infertility, and endometrial cancer. The use of D-chiro-inositol (DCI) for the treatment of IR in P ...
Abstract View Full Article View DOI: 10.17352/ijcem.000026

Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases

Published On: September 19, 2017 | Pages: 023 - 028

Author(s): El Gammal AT, Sturm JH, Pinnschmidt HO, Hofmann BT, Bellon E, et al
Objectives: S100A8/A9 expression has been linked to carcinogenesis and infl ammation. We hypothesized that S100A8/A9 protein serum levels are a useful stratifi cation marker for patients with pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP). ...
Abstract View Full Article View DOI: 10.17352/ijcem.000025

Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach

Published On: July 08, 2017 | Pages: 018 - 022

Author(s): Ipseeta Ray Mohanty*, Selvaa Kumar and Rajesh Suman
Background: Dipeptidyl peptidase-IV (DDP-IV) Inhibitors may represent single anti-diabetic drugs, the multiple actions of which may translate into demonstrable therapeutic benefi ts in diabetes. ...
Abstract View Full Article View DOI: 10.17352/ijcem.000024


Peertechz @Social

Peertechz Tweets

Case Reports

Pinterest on IJCEM